Olivier Sutter

1.4k total citations · 1 hit paper
39 papers, 878 citations indexed

About

Olivier Sutter is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Olivier Sutter has authored 39 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hepatology, 20 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Olivier Sutter's work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Liver Disease Diagnosis and Treatment (20 papers) and Liver Disease and Transplantation (13 papers). Olivier Sutter is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Liver Disease Diagnosis and Treatment (20 papers) and Liver Disease and Transplantation (13 papers). Olivier Sutter collaborates with scholars based in France, Italy and Switzerland. Olivier Sutter's co-authors include Jean‐Charles Nault, Olivier Séror, Nathalie Ganne‐Carrié, Pierre Nahon, G. Nkontchou, N. Sellier, Eric Trépo, Abou Diallo, Hervé Trillaud and Christophe Aubé and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Scientific Reports.

In The Last Decade

Olivier Sutter

35 papers receiving 871 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations

2017 293 citations Jean‐Charles Nault, Olivier Sutter et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olivier Sutter France	15	620	380	180	126	102	39	878
Jimmy Yuen Hong Kong	10	592 1.0×	287 0.8×	230 1.3×	122 1.0×	175 1.7×	12	868
Kai Feng China	13	665 1.1×	500 1.3×	267 1.5×	104 0.8×	136 1.3×	25	936
Tomonori Fujishima Japan	9	1.3k 2.1×	843 2.2×	376 2.1×	192 1.5×	154 1.5×	14	1.4k
Jun Gao China	17	359 0.6×	151 0.4×	315 1.8×	217 1.7×	189 1.9×	68	962
Jennie Engstrand Sweden	14	601 1.0×	110 0.3×	317 1.8×	246 2.0×	544 5.3×	35	1.1k
Alessandra R. Garcia United States	4	356 0.6×	95 0.3×	102 0.6×	97 0.8×	109 1.1×	4	458
Maarten C. Jansen Netherlands	9	363 0.6×	140 0.4×	142 0.8×	101 0.8×	181 1.8×	10	520
Takayuki Hamatsu Japan	14	377 0.6×	203 0.5×	365 2.0×	237 1.9×	302 3.0×	36	995
Jianmin Ding China	11	298 0.5×	199 0.5×	99 0.6×	55 0.4×	65 0.6×	36	464
Eriko Goto Japan	13	696 1.1×	679 1.8×	126 0.7×	63 0.5×	112 1.1×	23	920

Countries citing papers authored by Olivier Sutter

Since Specialization

Citations

This map shows the geographic impact of Olivier Sutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Sutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Sutter more than expected).

Fields of papers citing papers by Olivier Sutter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Sutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Sutter. The network helps show where Olivier Sutter may publish in the future.

Co-authorship network of co-authors of Olivier Sutter

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Sutter. A scholar is included among the top collaborators of Olivier Sutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Sutter. Olivier Sutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vithayathil, Mathew, et al.. (2025). Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinoma. Journal of Hepatology. 83(4). 959–970. 9 indexed citations

Blaise, Lorraine, Marianne Ziol, Claudia Campani, et al.. (2025). Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma. JHEP Reports. 7(9). 101430–101430. 1 indexed citations

Sutter, Olivier, et al.. (2025). Toward perioperative, numerically assisted irreversible electroporation for hepatocellular carcinoma: clinical outcomes informed by numerical simulations. European Radiology.

Sutter, Olivier, et al.. (2025). Correlation between computed electric dose maps and early post-operative MRI for the evaluation of irreversible electroporation. Physics in Medicine and Biology. 70(22). 225010–225010.

Pescatori, Lorenzo, G. Nkontchou, Abou Diallo, et al.. (2025). The role of early MRI in assessing the risk of local tumor progression following irreversible electroporation for hepatocellular carcinoma treatment. International Journal of Hyperthermia. 42(1). 2505595–2505595.

Nahon, Pierre, Maxime Ronot, Olivier Sutter, et al.. (2024). Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer. BMJ Open. 14(2). e083701–e083701. 8 indexed citations

Campani, Claudia, Manon Allaire, Philippe Sultanik, et al.. (2023). Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab. Hepatology. 79(1). 49–60. 14 indexed citations

Campani, Claudia, Lorraine Blaise, Nathalie Ganne‐Carrié, et al.. (2022). Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab. Liver International. 43(3). 708–717. 27 indexed citations

Sutter, Olivier, et al.. (2022). Automated needle localisation for electric field computation during an electroporation ablation. HAL (Le Centre pour la Communication Scientifique Directe). 1279–1284. 1 indexed citations

10.

Gigante, Elia, Jean‐Charles Nault, Olivier Sutter, et al.. (2022). Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation. Scientific Reports. 12(1). 18712–18712. 2 indexed citations

11.

Roth, Gaël S., Stefano Caruso, Christian Sengel, et al.. (2022). Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization. World Journal of Gastroenterology. 28(36). 5324–5337. 11 indexed citations

12.

Nahon, Pierre, Christophe Aubé, Lucile Moga, et al.. (2021). Non-invasive diagnosis and follow-up of primary malignant liver tumours. Clinics and Research in Hepatology and Gastroenterology. 46(1). 101766–101766. 2 indexed citations

13.

Ajavon, Y., et al.. (2021). Use of Virtual Target Fluoroscopic Display of Three-Dimensional CO2 Wedged Hepatic Vein Portography for TIPS Placement. CardioVascular and Interventional Radiology. 44(11). 1817–1822. 4 indexed citations

14.

Blaise, Lorraine, Héléna Pereira, Valérie Vilgrain, et al.. (2021). Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101731–101731. 1 indexed citations

15.

Allaire, Manon, Olivier Sutter, Pierre Nahon, et al.. (2019). TIPS for management of portal-hypertension-related complications in patients with cirrhosis. Clinics and Research in Hepatology and Gastroenterology. 44(3). 249–263. 20 indexed citations

16.

Paisant, Anita, Valérie Vilgrain, Jérémie Riou, et al.. (2019). Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs. Journal of Hepatology. 72(5). 937–945. 53 indexed citations

17.

Hocquelet, Arnaud, et al.. (2019). No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma. CardioVascular and Interventional Radiology. 43(2). 273–283. 19 indexed citations

18.

Allaire, Manon, Richard Layese, Erwan Guyot, et al.. (2018). Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis. Digestive and Liver Disease. 51(1). 86–94. 14 indexed citations

19.

Nkontchou, G., Jean‐Charles Nault, Olivier Sutter, et al.. (2018). Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas > 5 cm: Long-Term Results. Liver Cancer. 8(3). 172–185. 21 indexed citations

20.

Nault, Jean‐Charles, Olivier Sutter, Pierre Nahon, Nathalie Ganne‐Carrié, & Olivier Séror. (2017). Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. Journal of Hepatology. 68(4). 783–797. 293 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact